ScholarIQanswers from OpenAlex
Sarcoma Oncology Center
InstitutionResearch output, impact & collaborations
Sarcoma Oncology Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about Sarcoma Oncology Center?
ScholarIQrecord summary
Sarcoma Oncology Center is a research organisation in Santa Monica, US. OpenAlex records 991 works and 83,664 citations for it. 190 researchers list it as their most recent affiliation.
How many works does Sarcoma Oncology Center have?
ScholarIQindexed works
Sarcoma Oncology Center has 991 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sarcoma Oncology Center have?
ScholarIQcitation count
Sarcoma Oncology Center has 83,664 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Sarcoma Oncology Center?
ScholarIQresearcher count
Sarcoma Oncology Center has 190 researchers in the ScholarIQ index.
What is the average h-index at Sarcoma Oncology Center?
ScholarIQavg h-index
Sarcoma Oncology Center has an average h-index of 52.3 in OpenAlex.
What is the ROR of Sarcoma Oncology Center?
ScholarIQror
The ROR for Sarcoma Oncology Center is on the source record.
What is the OpenAlex record for Sarcoma Oncology Center?
ScholarIQopenalex
The OpenAlex for Sarcoma Oncology Center is on the source record.
Who are the most-cited researchers behind Sarcoma Oncology Center?
ScholarIQtop researchers by citations
What are the most-cited papers on Sarcoma Oncology Center?
ScholarIQmost cited works
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Thérese Sørlie, Charles M. Perou, Robert Tibshirani, Turid Aas, Stephanie Geisler, Hilde Johnsen, Trevor Hastie, Michael B. Eisen, Matt van de Rijn, Stefanie S. Jeffrey, Thor Thorsen, H. Quist, John C. Matese, Patrick O. Brown, David Botstein, Per Eystein Lønning, Anne‐Lise Børresen‐Dale
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares, Salvatore Siena, Alice T. Shaw, Anna F. Farago, Collin M. Blakely, Takashi Seto, Byoung Chul Cho, Diégo Tosi, Benjamin Besse, Sant P. Chawla, Lyudmila Bazhenova, John C. Krauss, Young Kwang Chae, Minal Barve, Ignacio Garrido‐Laguna, Stephen V. Liu, Paul Conkling, Thomas John, Marwan Fakih, Darren Sigal, Herbert H. Loong, Gary L. Buchschacher, Pilar Garrido, Jorgé Nieva, Conor Steuer, Tobias R. Overbeck, Daniel W. Bowles, Elizabeth Fox, Todd Riehl, Edna Chow‐Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, George D. Demetri
Genome-wide analysis of DNA copy-number changes using cDNA microarrays
Jonathan R. Pollack, Charles M. Perou, Ash A. Alizadeh, Michael B. Eisen, Alexander Pergamenschikov, Cheryl F. Williams, Stefanie S. Jeffrey, David Botstein, Patrick O. Brown
A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Margaret Town, G Jean, Stéphanie Cherqui, Marlene Attard, Lionel Forestier, S.A. Whitmore, David F. Callen, Olivier Gribouval, M. Broyer, Gillian P. Bates, William van’t Hoff, Corinne Antignac
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
Sant P. Chawla, Robert M. Henshaw, Leanne L. Seeger, Edwin Choy, Jean‐Yves Blay, Stefano Ferrari, Judith R. Kroep, R. J. Grimer, Peter Reichardt, Piotr Rutkowski, Scott M. Schuetze, Keith M. Skubitz, Arthur P. Staddon, David M. Thomas, Yi Qian, Ira Jacobs
How much of the research on Sarcoma Oncology Center is open access?
ScholarIQopen access share
67%OPEN ACCESS